The potentiation of radiation response in human colon carcinoma cells in vitro and murine lymphoma in vivo by AG337 (Thymitaq(TM)), a novel thymidylate synthase inhibitor

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 789-793

  Kim, Sang Hie ^a   Brown, Stephen L ^a   Kim, Jae Ho ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Radiation; Radiotherapy; Thymidylate Synthase Inhibitor

Indexed keywords

NOLATREXED; RADIOSENSITIZING AGENT; THYMIDYLATE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CELL SURVIVAL; COLON CARCINOMA; CONFERENCE PAPER; CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; ENZYME INHIBITION; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HT29 CELLS; HUMANS; LEUKEMIA L5178; MALE; MICE; MICE, INBRED DBA; QUINAZOLINES; THYMIDYLATE SYNTHASE;

EID: 0344835947     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00338-1     Document Type: Conference Paper

References (19)

1. Weber S.E., Bleckman T.M., Attard J., et al. Design of thymidylate synthase inhibitors using protein crystal structures The synthesis and biological evaluation of a novel class of 5-substituted quinazolinones . J Med Chem. 37:1993;733-746.
2. Bruso C.E., Shewach D.S., Lawrence T.S. Fluorodeoxyuridine-induced radiosensitization and DNA double strand break repair in human colon carcinoma cells. Int J Radiat Oncol Biol Phys. 19:1990;1411-1417.
3. Heidelberger C., Danenberg P.V., Moran R.G. Fluorinated pyrimidine and their nucleosides. Adv Enzymol Relat Areas Mol Biol. 54:1993;58-119.
4. Heimburger D.K., Shewach D.S., Lawrence T.S. The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells. Int J Radiat Oncol Biol Phys. 21:1991;983-987.
5. Lawrence T.S., Davis M.A., Maybaum J. Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int J Radiat Oncol Biol Phys. 29:1994;519-523.
6. Lawrence T.S., Maybaum J. Fluoropyrimidine as radiation sensitizer. Sem Radiat Oncol. 3:1993;20-28.
7. Miller E.M., Kinsella T.J. Radiosensitization by fluorodeoxyuridine Effects of thymidylate synthase inhibition and cell synchronization . Cancer Res. 52:1992;1687-1694.
8. Minsky B.D., Cohen A.M., Kemeny N., et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol. 10:1992;79-84.
9. Smalley S.R., Kimler B.F., Evans R.G. 5-fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int J Radiat Oncol Biol Phys. 20:1991;207-211.
10. Kim S.H., Khil M.S., Ryu S., et al. Enhancement of radiation response on human carcinoma cells in culture by pentoxifylline. Int J RadiatOncolBiol Phys. 25:1992;61-65.
11. Albright N. Computer program for the analysis of cellular survival data. Radiat Res. 112:1982;331-340.
12. Jackman A.L., Taylor G.A., Calvert A.H., et al. Modulation of anti-metabolite effects Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthase inhibitor, CB 3717 . Biochem Pharmacol. 33:1984;3269-3275.
13. Kim J.H., Alfieri A.A., Kim S.H., et al. The potentiation of radiation response on murine tumor by fludarabine phosphate. Cancer Lett. 31:1986;69-76.
14. Weber S., Bartlett C.A., Boritzki T.J., et al. AG337, a novel lipophilic thymidylate synthase inhibitor In vitro and in vivo preclinical studies . Cancer Chemother Pharmacol. 37:1996;509-517.
15. Washtien W.L. Comparison of 5-fluorouracil metabolism in two human gastrointestinal tumor cell lines. Cancer Res. 44:1984;909-914.
16. Cunningham D., Zalcberg J., Smith I., et al. "Tomudex" (ZD1694) A novel thymidylate synthase inhibitor with clinical antitumor activity in range of solid tumors . Annals Oncol. 7:1996;179-182.
17. Jackman A.L., Boyle F.T., Harrap K.R. Tomudex (ZD1694) From concept to care, a programme in rational drug discovery . Invest New Drugs. 14:1996;305-316.
18. Tang H.Y., Davis M.A., Strickfaden S.M., et al. Influence of cell cycle phase on radiation-induced cytotoxicity and DNA damage in human colon cancer (HT-29) and Chinese hamster ovary cells. Radiat Res. 138:1994;5109-5112.
19. Lawrence T.S., Davis M.A., Tang H.Y., et al. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S-phase progression. Int J Radiat Oncol Biol Phys. 70:1996;273-280.